Lactose (India) Limited (BOM:524202)
104.25
0.00 (0.00%)
At close: Mar 20, 2025
Lactose (India) Company Description
Lactose (India) Limited engages in the manufacture and trading of pharmaceutical products in India.
The company is involved in the production of drugs, medicines, chemicals, foods, etc. It offers lactose monohydrate; dry granulated, film, and lacquer coated tablets; and pharmaceutical products in solid dose forms.
In addition, the company provides disaccharide lactulose, an active pharmaceutical ingredient that is used in the treatment of constipation, hepatitis encephalopathy, intestinal microflora, dental care, diabetes, and chronic liver disease, as well as for use as a prebiotic.
It also exports its products. The company was incorporated in 1991 and is headquartered in Mumbai, India.
Lactose (India) Limited
Country | India |
Founded | 1991 |
Industry | Pharmaceutical Preparations |
Employees | 129 |
CEO | Atul Maheshwari |
Contact Details
Address: Unit No. G-02, 'A' wing, Ground Floor Mumbai, 400015 India | |
Phone | 91 22 3513 1864 |
Website | lactoseindialimited.com |
Stock Details
Ticker Symbol | 524202 |
Exchange | Bombay Stock Exchange |
Fiscal Year | April - March |
Reporting Currency | INR |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Atul Maheshwari | Chief Executive Officer |
Sangita Maheshwari | Chief Financial Officer |